The tweet was deleted by the author.
But we saved everything 🙂.
CME Group said it will let customers trade the performance of all 32 NHL teams through its new FSPI NHL futures, set for a September 28 start pending regulatory review. The stock edges lower on the day, trading at $275.53.
CME Group plans to launch trading on the performance of all 32 NHL teams beginning September 28, pending regulatory review. The new offering, called CME FSPI NHL futures, will allow clients to speculate on the teams using futures contracts. These instruments will be available in both standard and micro sizes and can be traded around the clock, subject to CFTC regulation.
View post on X Loading...
Price is currently testing resistance from the Ichimoku Kijun at $275.62. The daily setup is divided, with shares still below the MA-20 and MA-200 but holding above the MA-50. With Stoch RSI in oversold territory, further downside appears limited and the move has been muted.
Traders should watch for a close above $275.62 to indicate buyers are showing renewed commitment. Shares are pressing against resistance at this level without yet breaking through. Although the past week has been marked by a contained move within a narrow range, from here the upside probability is 72% and downside probability is 28%, with an expected trading range of $272.03 to $279.02 for the coming trading week. A break above $275.62 would confirm strength, while a decline below $269.92 would indicate the move is being faded. On the weekly chart, the longer-term picture stays constructive.
Previously it was reported that CME Group expanded its product suite with the launch of E-mini Factor futures, broadening investor access to targeted market benchmarks. The rollout of FSPI NHL futures adds a new dimension to CME’s offerings, and with price action still tightly contained, traders should monitor if a sustained move above $275.62 signals strengthening momentum in the coming sessions.